KRAS and pancreatic neoplasm: Sakamoto, K, et al. (2023) nanoformulated the K-Ras(G12D)-inhibitory bicyclic peptide KS-58 into micelles that demonstrated antitumor activity against colon and pancreatic tumors [88].